Periods | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | All Time |
---|---|---|---|---|---|---|---|
Primex-40 | |||||||
Capillary Technologies India Limited |
Particulars |
31-03-2024 |
31-03-2023 |
Non-current assets |
|
|
Property, plant and equipment |
26.00 |
22.56 |
Goodwill |
1,632.21 |
1,472.72 |
Intangible assets |
1,097.55 |
516.06 |
Right-of-use assets |
30.13 |
18.07 |
Intangible assets under development |
31.10 |
54.97 |
Other financial assets |
144.79 |
115.69 |
Non-current tax assets |
43.06 |
50.53 |
Deferred tax assets |
6.83 |
- |
Other non-current assets |
16.52 |
707.26 |
Current assets |
|
|
Investments |
699.25 |
- |
Trade receivables |
2,368.67 |
801.11 |
Cash and cash equivalents |
1,806.68 |
462.00 |
Loan receivables |
399.99 |
- |
Other financial assets |
27.70 |
159.07 |
Other current assets |
154.43 |
76.08 |
Total assets |
8,484.91 |
4,456.12 |
Equity |
|
|
Equity share capital |
146.46 |
105.79 |
Other equity |
5,019.64 |
1,558.64 |
Non-current liabilities |
|
|
Borrowings |
41.69 |
432.06 |
Lease liabilities |
8.01 |
2.10 |
Other financial liabilities |
18.53 |
18.53 |
Provisions |
66.11 |
43.24 |
Deferred tax liabilities |
92.64 |
55.15 |
Current liabilities |
|
|
Borrowings |
729.97 |
1,042.65 |
Lease liabilities |
23.42 |
17.94 |
Trade payables |
|
|
Total outsanding dues of micro enterprises and small enterprises |
73.95 |
28.77 |
Total outstanding dues of creditors other than above |
654.31 |
559.80 |
Other financial liabilities |
204.83 |
130.26 |
Other current liabilities |
1,362.02 |
428.21 |
Provisions |
19.33 |
31.95 |
Liabilities for current tax |
24.00 |
1.03 |
Total Equity and Liabilities |
8,484.91 |
4,456.12 |
Particulars |
2023-2024 |
2022-23 |
Income |
|
|
Revenue from operations |
5,902.45 |
3,226.81 |
Other income |
103.40 |
108.81 |
Total income |
6,005.85 |
3,335.62 |
Expenses |
|
|
Cost of campaign services |
417.03 |
482.86 |
Professional and consultancy expenses |
919.23 |
418.22 |
Employee benefit expense |
3,108.90 |
2,331.22 |
Finance costs |
177.08 |
112.39 |
Depreciation and amortisation expenses |
582.19 |
395.68 |
Other expenses |
1,440.44 |
636.34 |
Total expenses |
6,644.87 |
4,376.71 |
Loss before exceptional items and tax |
(639.02) |
(1,041.09) |
Exceptional items (net) |
- |
113.82 |
Loss before tax |
(639.02) |
(927.27) |
Current tax |
25.78 |
(4.01) |
Deferred tax expense/(Credit) |
(71.02) |
(46.07) |
Loss for the year |
(593.78) |
(877.19) |
Other comprehensive income/(loss) |
|
|
Items that will be reclassified to profit or loss in subsequent periods: |
|
|
Exchange differences on translation of foreign operations |
41.72 |
(61.16) |
Items that will not to be reclassified to profit or loss in subsequent periods: |
|
|
Re-measurement (losses) on defined benefit plan |
(4.06) |
(4.92) |
Total other comprehensive income/ (loss) for the period (net of tax) |
37.66 |
(66.08) |
Total comprehensive loss for the period (net of tax) (VII + VIII) |
(556.12) |
(943.27) |
Loss per equity share (EPS) (face value - ₹ 2 each) |
|
|
Basic (₹) |
(10.55) |
(17.53) |
Diluted (₹) |
(10.55) |
(17.53) |
Particulars |
31-03-2024 |
31-03-2023 |
Cash flow from operating activities |
|
|
Loss before exceptional items and tax |
(639.02) |
(1,041.09) |
Adjustments to reconcile loss before tax to net cash flows |
|
|
Depreciation and amortisation expenses |
582.19 |
395.68 |
Provision for doubtful trade receivables and advances (including bad debts written off) |
41.21 |
19.19 |
Employee stock option expenses |
68.84 |
591.48 |
Profit on sale of mutual fund |
(17.55) |
- |
Fair value change in financials assets measured at fair value through statement of profit and loss |
(9.59) |
- |
Interest income on income tax refund |
(2.58) |
|
Property, plant and equipment written off |
2.31 |
- |
Interest income on corporate deposit |
(6.50) |
- |
Provision / liabilities no longer required, written back |
(26.07) |
(38.22) |
Gain on account of foreign exchange fluctuations (net) |
(19.23) |
48.75 |
Interest income on bank deposits |
(12.64) |
(5.44) |
Finance costs |
168.30 |
102.34 |
Operating profit before working capital changes |
129.67 |
72.69 |
Working capital adjustments : |
|
|
Increase in trade receivables |
(347.29) |
(289.29) |
Decrease /(Increase) in non-current and current other financial and other assets |
66.37 |
(16.28) |
Increase in trade payables, non-current and current other financial, other liabilities and provisions |
976.17 |
10.70 |
Cash generated from / (used in) from operations |
824.92 |
(222.18) |
Direct taxes refund |
7.20 |
21.66 |
Net cash from / (used in) operating activities |
832.12 |
(200.52) |
Cash flow from investing activities |
|
|
Purchase of property, plant and equipment, intangible assets and intangible assets under development |
(369.32) |
(282.06) |
Proceeds from sale of property, plant and equipment |
1.80 |
- |
(Purchase) / sale of current investment, net |
(672.11) |
- |
Investments in corporate deposits |
(260.26) |
- |
Interest income on bank deposits |
10.78 |
2.06 |
Investment /(withdrawal) of bank deposits |
(29.10) |
40.34 |
Acquisition of a subsidiary |
(387.82) |
- |
Advance towards acquisition of a subsidiary |
- |
(696.59) |
Net cash used in investing activities |
(1,706.03) |
(936.25) |
Cash flow from financing activities |
|
|
Proceeds from issue of share capital |
1,337.43 |
820.60 |
Proceeds from issue of non convertible debentures |
50.00 |
544.00 |
Repayment of non convertible debentures |
(237.89) |
- |
Proceeds from issue of Compulsory Convertible Debentures (CCDs) |
1,701.50 |
- |
Repayment of long-term borrowings |
(366.82) |
(258.02) |
Payment of principal and interest portion of lease liabilities |
(24.23) |
(26.68) |
Proceeds from short-term borrowings (net) |
4.90 |
369.16 |
Finance costs paid |
(166.91) |
(75.42) |
Buy back of employee stock options |
(120.37) |
(7.92) |
Net cash from financing activities |
2,177.61 |
1,365.72 |
Net increase in cash and cash equivalents |
1,303.70 |
228.95 |
Cash and cash equivalents at the beginning of the year |
462.00 |
291.94 |
Effect of exchange differences on cash and cash equivalents held in foreign currency |
40.98 |
(58.89) |
Cash and cash equivalents at the end of the year |
1,806.68 |
462.00 |
Here is a summary of the Cash Flow Statement for the years 2024 and 2023:
Cash Flow from Operating Activities:
The company experienced a reduced loss before exceptional items and tax in FY2024 (Rs. 639.02 million) compared to FY2023 (Rs. 1,041.09 million). Adjustments like depreciation, provisions for doubtful debts, stock option expenses, and finance costs were added back to compute the operating profit before working capital changes. Significant working capital adjustments in FY2024 included an increase in trade receivables (Rs. 347.29 million) and trade payables (Rs. 976.17 million). These changes led to a positive cash flow of Rs. 832.12 million in FY2024, compared to a negative cash flow of Rs. 200.52 million in FY2023. This turnaround was primarily driven by higher operating profitability and favorable changes in liabilities.
Cash Flow from Investing Activities:
The company invested heavily in both fiscal years. In FY2024, cash outflows from investing activities amounted to Rs. 1,706.03 million, driven by large expenditures on property, plant, and equipment (Rs. 369.32 million), acquisition of a subsidiary (Rs. 387.82 million), and net purchases of current investments (Rs. 672.11 million). These activities were similar to FY2023, where the company had negative cash flows of Rs. 936.25 million, which included an advance towards the acquisition of a subsidiary (Rs. 696.59 million). Overall, cash flows from investing activities reflect the company’s significant capital expenditures and strategic investments.
Cash Flow from Financing Activities:
In FY2024, financing activities provided a significant inflow of Rs. 2,177.61 million, driven by proceeds from the issue of share capital (Rs. 1,337.43 million), compulsory convertible debentures (CCDs) (Rs. 1,701.50 million), and non-convertible debentures (Rs. 50 million). The company also repaid borrowings and debentures (Rs. 366.82 million and Rs. 237.89 million, respectively) and paid finance costs (Rs. 166.91 million). In FY2023, cash inflows from financing activities were lower, at Rs. 1,365.72 million, mainly driven by share capital proceeds and non-convertible debentures, reflecting a less aggressive approach compared to FY2024.
Particulars |
2024 |
2023 |
Current Ratio |
1.95 |
0.95 |
Debt-Equity Ratio |
0.16 |
0.65 |
Debt Service coverage ratio |
-0.2 |
-2.54 |
Return on Equity ratio |
-15.61% |
-50.70% |
Trade receivables turnover ratio |
2.31 |
1.54 |
Trade Payable Turnover Ratio |
1.86 |
1.69 |
Net Capital Turnover Ratio |
1.28 |
-15.42% |
Net Profit ratio |
36.71% |
59.99% |
Return on Capital employed |
7.36% |
26.98% |
Return on Investment |
8% |
5% |
Here is a summary of the financial and operational metrics for Capillary Technologies India Limited for the year 2024 and 2023:
Current Ratio:
The current ratio improved significantly in 2024 to 1.95 from 0.95 in 2023, indicating better short-term liquidity. A ratio above 1 shows that the company now has sufficient current assets to cover its current liabilities, reflecting a stronger liquidity position compared to the previous year.
Debt-Equity Ratio:
The debt-equity ratio fell from 0.65 in 2023 to 0.16 in 2024, highlighting a substantial reduction in the company’s reliance on debt financing. This lower ratio suggests that the company has either reduced its debt or increased its equity base, leading to a more conservative financial structure with less financial risk.
Debt Service Coverage Ratio (DSCR):
The DSCR, which measures the company’s ability to meet debt obligations, improved but remained negative at -0.2 in 2024, compared to -2.54 in 2023. While still negative, the improvement signifies that the company is moving toward a position where it can cover its debt payments from operating income, but challenges remain in fully servicing its debt.
Return on Equity (ROE):
The ROE ratio saw a notable improvement, rising from -50.70% in 2023 to -15.61% in 2024. While still negative, this indicates that the company is reducing its losses relative to shareholders' equity. A negative ROE suggests that the company is not generating profits for its shareholders, but the reduction in losses reflects a positive trend.
Trade Receivables Turnover Ratio:
The trade receivables turnover ratio increased from 1.54 in 2023 to 2.31 in 2024, indicating better efficiency in collecting receivables. A higher ratio suggests that the company is quicker in converting its credit sales into cash, which improves its cash flow management.
Trade Payable Turnover Ratio:
The trade payable turnover ratio slightly increased from 1.69 in 2023 to 1.86 in 2024, suggesting that the company is paying its suppliers more frequently. This marginal improvement reflects enhanced management of supplier payments, though the change is not very significant.
Net Capital Turnover Ratio:
The net capital turnover ratio improved dramatically in 2024 to 1.28 from a highly negative -15.42% in 2023. This positive shift means that the company is now generating revenue more efficiently with respect to its working capital. A positive ratio indicates a much healthier operational efficiency compared to the severe inefficiency in 2023.
Net Profit Ratio:
The net profit ratio declined from 59.99% in 2023 to 36.71% in 2024, although still reflecting strong profitability. This ratio shows the percentage of revenue that translates into profit. While the decrease suggests lower profitability compared to 2023, the company is still generating a significant margin on its revenues.
Return on Capital Employed (ROCE):
ROCE dropped from 26.98% in 2023 to 7.36% in 2024, indicating a significant decline in how effectively the company is using its capital to generate profits. This decline reflects a reduced efficiency in capital utilization, but it remains positive, suggesting that the company is still generating returns on its capital employed, albeit at a lower rate.
Return on Investment (ROI):
The ROI improved from 5% in 2023 to 8% in 2024, indicating better performance in generating returns from its investments. This positive change reflects stronger gains from investment activities, signaling enhanced effectiveness in utilizing investment capital.